Efficient and versatile manipulation of the peripheral CD4 + T‐cell compartment by antigen targeting to DNGR‐1/CLEC9A

Abstract

DC NK lectin group receptor‐1 (DNGR‐1, also known as CLEC9A) is a C‐type lectin receptor expressed by mouse CD8α + DC and by their putative equivalents in human. DNGR‐1 senses necrosis and regulates CD8 + T‐cell cross‐priming to dead‐cell‐associated antigens. In addition, DNGR‐1 is a target for selective in vivo delivery of antigens to DC and the induction of CD8 + T‐cell and Ab responses. In this study, we evaluated whether DNGR‐1 targeting can be additionally used to manipulate antigen‐specific CD4 + T lymphocytes. Injection of small amounts of antigen‐coupled anti‐DNGR‐1 mAb into mice promoted MHC class II antigen presentation selectively by CD8α + DC. In the steady state, this was sufficient to induce proliferation of antigen‐specific naïve CD4 + T cells and to drive their differentiation into Foxp3 + regulatory lymphocytes. Co‐administration of adjuvants prevented this induction of tolerance and promoted immunity. Notably, distinct adjuvants allowed qualitative modulation of CD4 + T‐cell behavior: poly I:C induced a strong IL‐12‐independent Th1 response, whereas curdlan led to the priming of Th17 cells. Thus, antigen targeting to DNGR‐1 is a versatile approach for inducing functionally distinct CD4 + T‐cell responses. Given the restricted pattern of expression of DNGR‐1 across species, this strategy could prove useful for developing immunotherapy protocols in humans.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 41

1. 1.

   Steinman RM. Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system. Nat. Med. 2007;13:1155-1159.

   Not in our library10.1038/nm1643

2. 2.

   Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419-426.

   Not in our library10.1038/nature06175

3. 3.

   Tacken PJ, de Vries IJ, Torensma R, Figdor CG. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 2007;7:790-802.

   Not in our library10.1038/nri2173

4. 4.

   Caminschi I, Lahoud MH, Shortman K. Enhancing immune responses by targeting antigen to DC. Eur. J. Immunol. 2009;39:931-938.

   Not in our library10.1002/eji.200839035

5. 5.

   Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 2002;196:1627-1638.

   Not in our library10.1084/jem.20021598

6. 6.

   Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, Soares H, Brimnes MK, et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 2004;199:815-824.

   Not in our library10.1084/jem.20032220

7. 7.

   Boscardin SB, Hafalla JC, Masilamani RF, Kamphorst AO, Zebroski HA, Rai U, Morrot A, et al. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J. Exp. Med. 2006;203:599-606.

   Not in our library10.1084/jem.20051639

8. 8.

   Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, Ravetch JV, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 2001;194:769-779.

   Not in our library10.1084/jem.194.6.769

9. 9.

   Sancho D, Mourão-Sá D, Joffre OP, Schulz O, Rogers NC, Pennington DJ, Carlyle JR, et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J. Clin. Invest. 2008;118:2098-2110.

   Not in our library10.1172/jci34584

10. 10.

    Soares H, Waechter H, Glaichenhaus N, Mougneau E, Yagita H, Mizenina O, Dudziak D, et al. A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. J. Exp. Med. 2007;204:1095-1106.

    Not in our library10.1084/jem.20070176

11. 11.

    Trumpfheller C, Finke JS, Lopez CB, Moran TM, Moltedo B, Soares H, Huang Y, et al. Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J. Exp. Med. 2006;203:607-617.

    Not in our library10.1084/jem.20052005

12. 12.

    Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 2005;6:1219-1227.

    Not in our library10.1038/ni1265

13. 13.

    Mahnke K, Qian Y, Knop J, Enk AH. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood. 2003;101:4862-4869.

    Not in our library10.1182/blood-2002-10-3229

14. 14.

    Yamazaki S, Dudziak D, Heidkamp GF, Fiorese C, Bonito AJ, Inaba K, Nussenzweig MC, et al. CD8+CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 2008;181:6923-6933.

    Not in our library10.4049/jimmunol.181.10.6923

15. 15.

    Villadangos JA, Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 2007;7:543-555.

    Not in our library10.1038/nri2103

16. 16.

    Merad M, Manz MG. Dendritic cell homeostasis. Blood. 2009;113:3418-3427.

    Not in our library10.1182/blood-2008-12-180646

17. 17.

    Caminschi I, Proietto AI, Ahmet F, Kitsoulis S, Shin Teh J, Lo JC, Rizzitelli A, et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood. 2008;112:3264-3273.

    Not in our library10.1182/blood-2008-05-155176

18. 18.

    Huysamen C, Willment JA, Dennehy KM, Brown GD. CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J. Biol. Chem. 2008;283:16693-16701.

    Not in our library10.1074/jbc.m709923200

19. 19.

    Galibert L, Diemer GS, Liu Z, Johnson RS, Smith JL, Walzer T, Comeau MR, et al. Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule. J. Biol. Chem. 2005;280:21955-21964.

    Not in our library10.1074/jbc.m502095200

20. 20.

    Sancho D, Joffre OP, Keller AM, Rogers NC, Martínez D, Hernanz-Falcón P, Rosewell I, et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature. 2009;458:899-903.

    Not in our library10.1038/nature07750

21. 21.

    Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, Yamazaki S, Cheong C, et al. Differential antigen processing by dendritic cell subsets in vivo. Science. 2007;315:107-111.

    Not in our library10.1126/science.1136080

22. 22.

    Boes M, Bertho N, Cerny J, Op den Brouw M, Kirchhausen T, Ploegh H. T cells induce extended class II MHC compartments in dendritic cells in a Toll-like receptor-dependent manner. J. Immunol. 2003;171:4081-4088.

    Not in our library10.4049/jimmunol.171.8.4081

23. 23.

    Longhi MP, Trumpfheller C, Idoyaga J, Caskey M, Matos I, Kluger C, Salazar AM, et al. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J. Exp. Med. 2009;206:1589-1602.

    Not in our library10.1084/jem.20090247

24. 24.

    Leibundgut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, Schweighoffer E, et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 2007;8:630-638.

    Not in our library10.1038/ni1460

25. 25.

    Leibundgut-Landmann S, Osorio F, Brown GD, Reis e Sousa C. Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood. 2008;112:4971-4980.

    Not in our library10.1182/blood-2008-05-158469

26. 26.

    Schnorrer P, Behrens GM, Wilson NS, Pooley JL, Smith CM, El-Sukkari D, Davey G, et al. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc. Natl. Acad. Sci. USA. 2006;103:10729-10734.

    Not in our library10.1073/pnas.0601956103

27. 27.

    Scheinecker C, McHugh R, Shevach EM, Germain RN. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 2002;196:1079-1090.

    Not in our library10.1084/jem.20020991

28. 28.

    Boonstra A, Asselin-Paturel C, Gilliet M, Crain C, Trinchieri G, Liu YJ, O'Garra A. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J. Exp. Med. 2003;197:101-109.

    Not in our library10.1084/jem.20021908

29. 29.

    Manickasingham SP, Edwards AD, Schulz O, Reis e Sousa C. The ability of murine dendritic cell subsets to direct T helper cell differentiation is dependent on microbial signals. Eur. J. Immunol. 2003;33:101-107.

    Not in our library10.1002/immu.200390001

30. 30.

    Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, et al. Conversion of peripheral CD4+CD25- naïve T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 2003;198:1875-1886.

    Not in our library10.1084/jem.20030152

31. 31.

    Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 2007;204:1757-1764.

    Not in our library10.1084/jem.20070590

32. 32.

    Guilliams M, Crozat K, Henri S, Tamoutounour S, Grenot P, Devilard E, de Bovis B, et al. Skin-draining lymph nodes contain dermis-derived CD103- dendritic cells that constitutively produce retinoic acid and induce Foxp3+ regulatory T cells. Blood. 2010;115:1958-1968.

    Not in our library10.1182/blood-2009-09-245274

33. 33.

    Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood. 2005;105:4743-4748.

    Not in our library10.1182/blood-2004-10-3932

34. 34.

    Maldonado-López R, De Smedt T, Michel P, Godfroid J, Pajak B, Heirman C, Thielemans K, et al. CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 1999;189:587-592.

    Not in our library10.1084/jem.189.3.587

35. 35.

    Perrigoue JG, Saenz SA, Siracusa MC, Allenspach EJ, Taylor BC, Giacomin PR, Nair MG, et al. MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat. Immunol. 2009;10:697-705.

    Not in our library10.1038/ni.1740

36. 36.

    Sokol CL, Chu NQ, Yu S, Nish SA, Laufer TM, Medzhitov R. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat. Immunol. 2009;10:713-720.

    Not in our library10.1038/ni.1738

37. 37.

    Yoshimoto T, Yasuda K, Tanaka H, Nakahira M, Imai Y, Fujimori Y, Nakanishi K. Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat. Immunol. 2009;10:706-712.

    Not in our library10.1038/ni.1737

38. 38.

    Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 1999;189:821-829.

    Not in our library10.1084/jem.189.5.821

39. 39.

    Corbett AJ, Caminschi I, McKenzie BS, Brady JL, Wright MD, Mottram PL, Hogarth PM, et al. Antigen delivery via two molecules on the CD8- dendritic cell subset induces humoral immunity in the absence of conventional “danger”. Eur. J. Immunol. 2005;35:2815-2825.

    Not in our library10.1002/eji.200526100

40. 40.

    He LZ, Crocker A, Lee J, Mendoza-Ramirez J, Wang XT, Vitale LA, O'Neill T, et al. Antigenic targeting of the human mannose receptor induces tumor immunity. J. Immunol. 2007;178:6259-6267.

    Not in our library10.4049/jimmunol.178.10.6259

Cited by papers we hold 6

• Dendritic Cells and Their Role in Immunotherapy · 2020
  No notice
• The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination · 2018
  Not checked
• CLEC10A Is a Specific Marker for Human CD1c+ Dendritic Cells and Enhances Their Toll-Like Receptor 7/8-Induced Cytokine Secretion · 2018
  No notice
• Mechanisms of Tolerance Induction by Dendritic Cells In Vivo · 2018
  No notice
• The role of FcRn in antigen presentation · 2014
  Not checked
• Targeting Antigens to Dendritic Cell Receptors for Vaccine Development · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.